Literature DB >> 3129521

Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.

J Bissett1, M Eisenberg, P Gregory, W S Robinson, T C Merigan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3129521     DOI： 10.1093/infdis/157.5.1076

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

1.  Combination therapy for hepatitis B.

Authors:  A M Di Bisceglie
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 2.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

3.  Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferon-gamma.

Authors:  Mohammad-Khalid Parvez; Deepak Sehgal; Shiv-Kumar Sarin; Seemi-Farhat Basir; Shahid Jameel
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.